GlassScriptPhysician profile
Ashaki Warren
NPI 1437416286
$2,042.99
in general payments reported to CMS, 2019-2025
15 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $341 · 2022: $22.81 · 2023: $227 · 2024: $112 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $379.28 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $364.24 | 2019-2025 | Invega Sustenna, Invega |
| Takeda Pharmaceuticals U.S.A., INC. | $221.22 | 2019-2020 | |
| Lundbeck LLC | $202.98 | 2019-2020 | |
| Alkermes, INC. | $185.37 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $181.39 | 2019-2024 | Uzedy |
| Ironshore Pharmaceuticals INC. | $120.54 | 2019-2020 | |
| Orexo US, INC. | $112.16 | 2019 | |
| Idorsia Pharmaceuticals US INC | $88.16 | 2023 | Quviviq |
| Mdd US Operations, LLC | $60.78 | 2019 | |
| Vanda Pharmaceuticals INC. | $51.32 | 2019-2020 | |
| Kaleo, INC. | $25.49 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.11 | 2019 | |
| Shire North American Group INC | $16.41 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashaki Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.